| Wesley I. Sundquist | |
| Birth Place: | Saint Paul, Minnesota, US |
| Fields: | Biochemistry |
| Alma Mater: | Carleton College (b.a; 1981)Massachusetts Institute of Technology (PhD; 1988) |
| Doctoral Advisor: | Sir Aaron Klug |
Wesley I. Sundquist (born 1959) is an American biochemist. Sundquist is known for studying the cellular, molecular and structural biology of retroviruses, particularly HIV. He is also known for studying the ESCRT pathway in cell division.[1]
Sundquist was born in Saint Paul, Minnesota in 1959. He grew up in Saint Paul and Washington, D.C. He received his bachelor's degree in chemistry from Carleton College in Minnesota in 1981. During his time at Carleton Sundquist served as the coordinator of the Faribault Project, was elected to Sigma Xi and received a National Merit Scholarship (1977–81). Sundquist went on to complete a PhD at the Massachusetts Institute of Technology with Stephen J. Lippard in 1988. Following his PhD, he participated in postdoctoral research at the MRC Laboratory of Molecular in Cambridge, England under Sir Aaron Klug. In 1992, Sundquist joined the University of Utah Department of Biochemistry.[2]
Sundquist is Distinguished Professor and Chair of the Department of Biochemistry at the University of Utah, and he also directs a research lab. The Sundquist Lab focuses on cellular, molecular and structural biology of retroviruses with a focus on Human Immunodeficiency Virus (HIV). Major projects in his lab include, enveloped virus assembly ESCRT pathway functions and regulation in cell division and cancer, and HIV capsid structure, replication and restriction.[3]
To leave a cell and spread infection, HIV viral particles must become enveloped within a membrane and bud from the cell. Sundquist found that retroviruses like HIV bud from infected cells using the host Endosomal Sorting Pathway Required for Transport or ESCRT pathway. HIV also uses the host proteins of the Angiomotin family to facilitate membrane envelopment prior to ESCRT- mediated budding. Sundquist's current research in this area focuses on understanding assembly and budding of HIV, characterizing the host and viral proteins involved, and testing innate immune restriction of viruses that use the ESCRT pathway. The Sundquist lab has also used their understanding of the requirements and principles of enveloped virus assembly to design and characterize new proteins that can assemble into nanocages, bud from cells, and carry cargoes into new target cells.
The ESCRT pathway facilitates formation of vesicles that bud into the endosome, neuronal pruning, reassembly of the post-mitotic nuclear envelope, final stage cell division (cytokinetic abscission). Cytokinetic abscission completes the separation of the two daughter cells, and also helps to coordinate a checkpoint that delays cell division until mitotic processes are completed successfully. In some cancer cells, this regulation doesn’t function correctly. Sundquist’s lab is studying these processes by determining the structures and functions of individual ESCRT proteins and the cofactors they recruit to help mediate abscission and the abscission checkpoint, and the signaling pathways that control their activities.
The capsid of HIV facilitates viral reverse transcription and protects the viral genome from the innate immune system. Sundquist defined the fullerene cone structure of the viral capsid, helping to set the stage for development of highly potent and long-lasting capsid inhibitors at Gilead Sciences. The Sundquist lab was also the first to reconstitute HIV reverse transcription and integration in a cell-free system. Sundquist and his collaborators also helped to define how the host restriction factor, TRIM5alpha recognizes and assembles around the capsid.
In 1993, Sundquist received the Searle Scholars Award.
In 2004, he received both the MERIT award from the National Institutes of Health and the Bernard Fields award for Retrovirology.
He has been elected to the American Academy of Arts and Sciences (2011) and the National Academy of Sciences. (2014).